A multicenter study conducted in the UK and Ireland found that single-use rhinolaryngoscopes offered organizational benefits over reusables.
The research presented to the American Rhinologic Society (ARS) meeting in a poster at COSM in May showed that clinicians perceived single-use rhinolaryngoscopes to have better organizational impact in nine out of 10 categories, with seven categories showing statistically significant differences favoring single-use devices.
The study evaluated 156 surveys distributed to managers, clinicians and nurses at five hospitals in the UK and Ireland. Those surveyed worked in a variety of hospital departments including ICUs, emergency departments and endoscopy units.
Related: University Touts Transition to Single-Use Rhinolaryngoscopes
The survey categories showing statistical significance were:
The need for reprocessing and repairs is eliminated with single use rhinolaryngoscopes like those offered by Ambu. The endoscopes are sterile straight from the pack and brand new for each patient, eliminating concerns about cross-contamination.
In a separate study, physicians at multiple academic hospitals across the U.S. scored the Ambu single-use rhinolaryngoscope superior in setup and convenience and better overall than its reusable competitors. Those findings were detailed in a study published in Laryngoscope Investigative Otolaryngology.